Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trialPaul G. Richardson, Yen Charles, Mónica Galli et al.|The Lancet Oncology|2019Cited by 386
A Percutaneous Subcostal Approach for Intercostal StonesJameel Rehman, David B. Samadi, Bilal Chughtai et al.|Journal of Endourology|2008Cited by 7